ClinicalTrials.gg

Program

GB-0895

A development code. Also written as “GB-0895 (SC)”.

Its studies are mostly in Asthma, led by Generate Biomedicines.

Furthest: phase 3, since Dec 1, 20253 company-led studies, 3 open or runningNext primary completion: May 2027 (phase 1)

Who develops it

Each company that leads studies of it, as its sponsor page counts them.

CompanyStudies it leadsFurthest phaseFirst studyNext primary completion
Generate Biomedicines33 open or runningphase 3since Dec 1, 2025Jul 23, 2025May 2027phase 1 · NCT07116889

History and what’s ahead

From the studies’ own records, by the day each was first submitted. Purple marks an event: a company’s first study, a phase reached, a study stopped, a primary completion moved later (stops and moved dates are recorded from Sep 25, 2026). Dates ahead are the sponsors’ estimates.

  1. Jul 23, 2025First study: phase 1 study in AsthmaFirst studyNCT07116889 · 156 enrolled · United States, Germany, United Kingdom
  2. Dec 1, 2025Phase 3 study in AsthmaPhase 3 reachedNCT07276724 · 786 planned · United States, Brazil, Bulgaria and more
  3. Jan 21, 2026Phase 3 study in AsthmaNCT07359846 · 786 planned · United States, Argentina, Australia and more

Ahead

  1. May 2027Primary completion: phase 1 study in AsthmaNCT07116889
  2. Dec 2028Primary completion: phase 3 study in AsthmaNCT07276724
  3. Jan 2029Primary completion: phase 3 study in AsthmaNCT07359846

TargetBeta

Not stated by its company or a source we have read. Most early programs say nothing of it.

Studies

All 3 led by companies developing it, newest first. Each opens its study page.

StudyPhaseStatusPrimary completionSize
NCT07359846Asthma · United States, Argentina, Australia and more3RecruitingJan 2029786
NCT07276724Asthma · United States, Brazil, Bulgaria and more3RecruitingDec 2028786
NCT07116889Asthma · United States, Germany, United Kingdom1Active, not recruitingMay 2027156

How it is read

Names in the registry

  • “GB-0895”, 2 entries
  • “GB-0895 (SC)”, 2 entries

Codes read as this program: GB0895.

Conditions, from the studies’ own filings

First seen by our ledger Nov 13, 2026.

What this can’t show

  • Only studies on ClinicalTrials.gov. Studies only in China’s, Europe’s or other registries are missing here.
  • Deals, prices and results are not in the registry. A licence or acquisition shows only with a dated source.
  • Primary completion dates are the sponsors’ estimates and often move.
  • A study counts here when it names this program among the drugs it tests; one that writes it only beside a placebo may be missed.